SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Novel antiviral and immune targets to cure HBV - Fabien Zoulim, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019The initial Phase 1 evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254 - Samit Joshi, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019In silico design of a microarray patch as a multipurpose prevention technology - Rajith RajoliView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Efavirenz pharmacokinetics in HIV/TB coinfected persons initiating ART while receiving high dose rifapentine - Anthony Podany, PharmDView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019The ‘third wave’ of TB drug development what’s on the horizon (for patients with or without HIV) - Kelly Dooley, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 201950% Adherence is enough with modern ARVS, right - Terrence Blaschke, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Drug-drug interactions: All you need to know beyond www.hiv-druginteractions.org - Marta Boffito, MD, PhDView Slideset
VideoViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019CRISPR/Cas and Gene Editing for HIV - Paula CannonView Video
VideoViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Discussion)View Video
VideoViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Pro) - Jose ArribasView Video
VideoViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Dual Maintenance for HIV: Why Fix it if it's not Broken? (Debate: Con) - Andrew HillView Video
VideoViral Hepatitis and Liver DiseaseRSVHIVInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2019Clinical Case Presentation - Catia MarzoliniView Video
